Next Study Group Webinar

Jointly organized by the Onco-Immunology and Chemistry Study Groups.

T Cells: Chemistry Meets Therapy

Date:

17 December 2025
15:00-16:00 CET

Speaker 1:

Stephan Fricke, Leipzig
“T cell therapies – Clinical stage of the art and current challenges.”

Speaker 2:

Daniëlle Vugts, Amsterdam
“Radiolabeling T cells for in vivo cell tracking.”

Chairs:

Kristina Djanashvili, Delft / Andreas Maurer, Leipzig / Sandra Heskamp, Nijmegen /Timo De Groof, Brussels

Organiser:

This seminar is chaired and organised jointly by the Chemistry and Onco-Immunology Study Groups

Stephan Fricke is Head of the Department of Cell and Gene Therapy Development at the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig, where his work focuses on the development and clinical application of Advanced Therapy Medicinal Products (ATMPs).

Daniëlle Vugts is Associate Professor at the Amsterdam VU University Medical Centre. She has a PhD in organic chemistry and over 12 years’ experience in radiochemisty.

Study Group Importance & Purpose

The Oncoimmunology and Therapy study group strongly believes that in vivo imaging is an essential part of the translation of new concepts and immunotherapies to the benefit of patients, by facilitating:

  • studies to further improve our mechanistic understanding of the immune system
  • studies to better understand the mechanisms of action of existing and new immunotherapies in preclinical and clinical settings
  • hypothesis-driven design of new immunotherapeutics and combination therapies.
We therefore will act to:
  • reach out and advertise use of imaging in different immunotherapy areas
  • further spread implementation of imaging into oncoimmunology and immunotherapy research through information and education
  • stimulate new scientific collaborations with related interest groups and scientific communities (CIMT, ESMO, ISCT etc.) that foster all of the above mentioned aims.

Group Review Article

The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies
Fruhwirth, G.O., Kneilling, M., de Vries, I.J.M., Weigelin, B., Srinivas, M., Aarntzen, E.H.J.G.

Founding Members:

  • Nicolas Beziere, Tübingen
  • Leo Carlin, Glasgow
  • Harald Carlsen, Oslo
  • Jolanda de Vries, Nijmegen
  • Marco Erreni, Milan
  • Peter Friedl, Nijmegen/Nijmegen
  • Manfred Kneiling, Tübingen
  • Ferdinand Knieling, Erlangen
  • Laura Mezzanotte, Rotterdam
  • Wouter Nagengast, Groningen
  • Geert Raes, Brussels
  • Bettina Weigelin, Tübingen

Group Leadership

  • Chair: Sandra Heskamp, Nijmegen
  • Co-Chair: Timo De Groof, Brussels
Interested in joining a Study Group?

You are an ESMI member already? Just log-in to your ESMI member portal, proceed to “Profile” and sign-in to any Study Group you are interested in.

Member Portal

Not a member yet?

Proceed to the Member Portal and register – it is just 85€/year, 20€/year for PhD students.

Become a member.